Loading
Latest filing published 30 Mar 2023 for Codiak BioSciences, Inc., €1,792.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Sriram Sathyanarayanan is a declared insider of Codiak BioSciences, Inc. (senior executive), with filings sourced from SEC (Form 4). The record holds 12 filings, for trades running from 6 August 2021 to 29 March 2023.
Every open-market trade on record is a sale: 7 sales worth €55k. Outside the open market, there are 5 option exercises. So far in 2023, the count stands at no purchases and 4 sales.
The latest filing, published on 30 March 2023, reports an open-market sale of €1,792 in Codiak BioSciences, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 50 days. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations